| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.041 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |